HercepTest Kit May Miss Some HER2+ Breast Cancers HercepTest Kit May Miss Some HER2+ Breast Cancers

A new, FDA-approved kit for determining HER2 status in breast cancer proved to be less accurate than standard tests in this study.American Journal of Clinical Pathology

Source: Medscape Today Headlines - May 7, 2019 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news